WS #2575

The dominant market signal remains the escalating Middle East conflict, with President Trump's 48-hour ultimatum to Iran to reopen the Strait of Hormuz (deadline 23:44 GMT Monday) triggering immediate risk-off moves. European stock indices are sharply down (Milan -2.5%, Frankfurt -1.8%, Paris -1.49%, London -1.55%), oil prices have surged (Brent above $113/barrel, WTI near $99), and bond yields are rising (Italian 10-year at 4.1%). The German Shipowners' Association warns that over 2,000 merchant ships with 20,000 crew are trapped in the Persian Gulf, with 20 ships already attacked, causing casualties—this directly threatens global trade flows and energy supply chains. Concurrently, a drone attack on Russia's Primorsk oil export terminal (the largest in western Russia) adds further supply-side pressure. These developments corroborate earlier warnings of an energy crisis worse than the 1970s oil shocks, with specific bearish pressure on broad indices (SPY, QQQ) and energy-sensitive sectors, while bullish for oil prices and defensive commodities. Secondary signals include corporate developments that are largely muted by the geopolitical shock but offer specific ticker implications. Elon Musk's Terafab project announcement (joint Tesla-SpaceX $20 billion chip fab targeting 2nm and 1 terawatt AI chips) is corroborated by GDELT reports, potentially boosting TSLA and NVDA sentiment amid the semiconductor focus. In biotech, Pyxis Oncology (PYXS) reported a Q4 EPS beat ($0.29 loss vs. $0.33 estimate) and sales of $11.038M, a positive signal for the stock. Synopsys (SNPS) shares are higher on reports of activist investor Elliott Capital building a multibillion-dollar stake, indicating potential M&A or strategic shifts. However, these are overshadowed by the broader market turmoil, with sentiment sharply bearish due to the oil price spike and equity sell-off.